Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

information)(Unaudited)Three Months EndedNine Months EndedSeptember 30, September 30,2010200920102009Revenue:Product sales and royalties

$  7,230$
7,461$  21,968$  24,456License, collaboration and other

30,6952,76291,7578,466Total revenue

37,92510,223113,72532,922Operating costs and expenses:Cost of goods sold

6,2456,13415,43022,139Research and development

27,72423,03176,61070,396General and administrative

10,1819,91729,40130,024Total operating costs and expenses

44,15039,082121,441122,559Income (loss) from operations

(6,225)(28,859)(7,716)(89,637)Non-operating income (expense):Interest income

3695601,2253,160Interest expense

(2,826)(2,928)(8,686)(9,213)Other income, net

249120436368Total non-operating expense

(2,208)(2,248)(7,025)(5,685)Loss before provision (benefit) for income taxes

(8,433)(31,107)(14,741)(95,322)Provision (Benefit) for income taxes

278(140)617(479)Net loss

$ (8,711)$ (30,967)$ (15,358)$ (94,843)Basic and diluted net loss per share

$   (0.09)$
(0.33)$
(0.16)$
(1.02)Weighted average shares outstanding used incomputing basic and diluted net loss pershare

94,21392,78993,97292,621NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands)(Unaudited)Nine Months Ended Sept 30,20102009Cash flows from operating activities:Net loss

$ (15,358)$   (94,843)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization

12,49911,076Stock-based compensation

12,7167,290Deferred rent

1,084-Other non-cash transactions

(1,260)(124)Changes in operating assets and liabilities:Accounts receivable

(752)4,505Inventory

(4,989)389Other assets

1(1,272)Accounts payable

1,755(4,047)Accrued compensation

500(1,859)Accrued expenses

4,090(4,610)Accrued clinical trial expenses


'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals International, ... has priced its previously announced public offering of common ... will issue 23,529,412 common shares at a price of ... $2.0 billion. The Company will file a final prospectus ... S-3 and will make a similar filing with the ...
(Date:6/18/2013)... June 18, 2013  It has become apparent ... Seating and Mobility, a subsidiary company of The ... repair. This appears to be due to the ... field service employees.  (Logo: ... of these clients are complex mobility users with ...
(Date:6/18/2013)... GARDEN CITY, N.Y. , June 18, 2013 ... announced that it has entered into an exclusive ... and Mid-Atlantic regions with eWellness Corporation ("EWC") for ... "An easy to use physical therapy program ... of diabetes and cardiovascular disease," said Chris ...
Breaking Medicine Technology:Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3
... Aug. 26 Semafore Pharmaceuticals Inc.,announced data presented ... Cancer in Washington, D.C., showing additional antiangiogenic,activity of ... VEGF and Bv8 signaling., PI3K is part ... pathway that,has been shown to play a major ...
... 26 XTENT, Inc.,(Nasdaq: XTNT ) today announced ... trial was published in the most recent issue of ... was,Dr. Pieter R. Stella, M.D., of University Medical Center ... Investigators from 13 clinical,sites across Europe., The one-year ...
Cached Medicine Technology:SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4
(Date:6/19/2013)... Chicago is cracking down on bed bugs. New legislation ... require landlords to exterminate any and all reported bed bug ... also makes tenants responsible for reporting signs of bed bugs ... include disposing of furniture, bedding, and more. , In January ... more bed bug business in Chicago than any other city. ...
(Date:6/19/2013)... North American Seminars combines a live ... with an online continuing education course directed at ... , The two day live physical ... online continuing education course will provide the ... needed to evaluate and treat dizziness and imbalance. ...
(Date:6/19/2013)... A blow to the head; a swift jarring to ... to hours. It’s understandable, but what else may follow ... traumatic brain injury. According to mayoclinic.com , usual ... But many other symptoms may follow, sometimes not for ... include ongoing headaches, dizziness, feeling like you’re in a fog, ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The website ... describing insulin resistance, its harmful effects and tips to ... article and video from HealthNewsWires.com, the author defines ... ability to efficiently remove and process glucose from the ... source required by all cells, organs and systems of ...
(Date:6/19/2013)... 2013 Audibel Hearing Center is ... tinnitus patients, the A2 with Multiflex Tinnitus Technology. ... ringing in the ears. Although bothersome, tinnitus usually ... body. , Using their patent-pending Multiflex Tinnitus Technology, ... comforting sound stimulus that resonates through the patient’s ...
Breaking Medicine News(10 mins):Health News:Chicago Ordinance Requires Landlords and Tenants to Take Responsibility for Bed Bugs 2Health News:New Evidence Based Information on Treatment for Over 8 Million People in the U.S. Affected With Disorders of the Vestibular System 2Health News:Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist 2Health News:Effects of Insulin Resistance and How to Increase Insulin Sensitivity Published in New Video by Health News Wire 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2
... best cigarette is no cigarette, but for the millions ... researchers from Cornell University may have found a way ... antioxidant extracts in cigarette filters, the researchers were able ... reduced the amount of cancer-causing free radicals passing through ...
... studies suggests that there may be a positive relationship ... according to a report in the January issue of ... of the JAMA/Archives journals. Amika Singh, Ph.D., of ... Health and Care Research, Amsterdam, the Netherlands, and colleagues ...
... News) -- Losing weight is one of the most common ... in itself, a medical expert says. To shed unwanted ... to face some setbacks and keep on trying, said Dr. ... Gottlieb Memorial Hospital, part of the Loyola University Health System. ...
... News) -- Researchers have identified three gene abnormalities that ... cancer, with one in particular -- the PTEN gene ... Dr. Charis Eng, founding director of the Genomic Medicine ... a news release that her team,s "investigation into the ...
... -- Drug users who inject themselves with methamphetamine are ... abusing other drugs, new research reveals. The magnified ... mixture of social, structural and neurobiological factors, say researchers ... New York City and the University of British Columbia ...
... HealthDay Reporter , FRIDAY, Dec. 30 (HealthDay News) -- ... was 19 years old and a student at the University ... Md., Keys had been suffering the classic symptoms before her ... to just go to the doctor," she recalled. "That,s when ...
Cached Medicine News:Health News:Physical activity, school performance may be linked 2Health News:Persistence Is Key to Losing Weight and Keeping It Off 2Health News:Persistence Is Key to Losing Weight and Keeping It Off 3Health News:Gene Mutations Linked to Thyroid Cancer Risk: Study 2Health News:Meth Users Much More Likely to Try Suicide 2Health News:A Life-Saving Lesson That Took Decades to Learn 2
The Diagnostic Automation, Inc. (DAI) Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of IgM antibody to Measles in human serum....
... over 30 years, Digisonics has set ... with the first review station, the ... and the best multi-modality reporting., ,DigiView ... image review workstations, professional reporting choices, ...
... Cortisol is a glucocorticoid produced by ... hormone (ACTH). It is secreted with a ... waking in the morning. Cortisol is often ... of hypertension, stress, AIDS, and in the ...
... IMMULITE 2500 is a high-throughput immunoassay ... ,of the IMMULITE 2000 with the important ... technology ,allows assays to be designed for ... times. ,This allows for critical assays such ...
Medicine Products: